Status:
COMPLETED
Optimization of the Sensitivity of Histological Diagnosis of Pulmonary Nodules
Lead Sponsor:
Elsan
Conditions:
Nodule
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In pulmonary oncology, the diagnosis of medium-sized pulmonary nodules (10 to 20 mm), too distal to be reached by standard bronchial fibroscopy but remaining proximal, is difficult. There are 2 techn...
Detailed Description
Concerning the interventional pneumology technique, it is performed in two steps: identification of the mass with the mini ultrasound probe and then distal sampling with a small biopsy forceps. Experi...
Eligibility Criteria
Inclusion
- Patient with a tumor of any location with a draining bronchus (primary lung cancer or lung metastases)
- Suspected lung nodule(s) with anatomical situation on mid 1/3 CT
- Presence of at least one lung nodule of sufficient size on CT to allow for at least 8 tissue samples
- Male or female aged ≥ 18 years
- Mandatory membership in a health insurance plan
- Patient who has been informed about the study and has signed the informed consent form
Exclusion
- Proximal or distal pulmonary nodule(s)
- Pacemaker patient
- Pregnant or nursing women
- Patients under legal protection
Key Trial Info
Start Date :
November 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT05230992
Start Date
November 5 2022
End Date
December 31 2023
Last Update
February 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pneumologie Elsan Santé Atlantique
Saint-Herblain, France, 44800